Dr. Sherif Elhosseiny, MD

Dr. Elhosseiny practices at Northern Dutchess Hospital in Rhinebeck, New York, part of Northwell Health.

Dr. Elhosseiny's NPI, 1679928584, was assigned on April 28, 2016. Dr. Elhosseiny holds New Jersey license 25MA10526000.

Dr. Elhosseiny's primary practice is Northern Dutchess Hospital, at 6511 Springbrook Avenue, Rhinebeck, NY 12572 in Dutchess County. The practice phone is (845) 871-3391.

Dr. Elhosseiny's primary practice is Northern Dutchess Hospital in Rhinebeck, New York, part of Northwell Health. Dr. Elhosseiny is also affiliated with Robert Wood Johnson University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Elhosseiny to 5 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elhosseiny practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Elhosseiny's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Elhosseiny is licensed in New Jersey.

CMS data shows 87 Medicare services from Dr. Elhosseiny across 1 procedure code in 2024, for 63 Medicare patients. Medicare paid $5,884 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 63 Medicare patients who saw Dr. Elhosseiny in 2024. The largest group is 75 to 84, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elhosseiny's median patient age at 75, with 50% women.

In 2024, Dr. Elhosseiny wrote 149 Medicare Part D claims for 45 patients. 80% of them were for generic drugs. CMS names the drug for 54 of them, across 3 drugs with 11 or more claims each, at $66,767 in total drug cost. In 2023, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Elhosseiny for performance year 2024, reported as part of a group. Dr. Elhosseiny accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of coronary angioplasty and stenting by Dr. Elhosseiny, more than 37% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 116 general payments to Dr. Elhosseiny from 18 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 49% of the total. Abbott Laboratories paid the most, $3,776.